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Introduction
A National Cancer Institute (NCI)-designated cancer center 
is an important resource to its community and is mandated 
to decrease cancer incidence and mortality among popula-
tions within its catchment area (CA), including minority and 
underserved populations. A CA is the geographic area and 
population from which a cancer center draws patients. Defin-
ing a CA allows a medical center to describe its primary patient 
population and assess how well it meets the needs of patients 
within the CA. A CA should capture a significant portion of 
the hospital’s activity and exclude areas whose contribution 
to hospital activity probably represents random variation. It 
should also reflect geographical and demographic influences 
on hospital activity, including physical barriers to access and 
competition, and be proportional in geographic size to hospi-
tal size.1 A defined CA is important for an NCI Cancer Cen-
ter, as it is required as part of the application for the NCI 
Cancer Center Support Grant (CCSG) process. According to 
the NCI CCSG guidelines (February 19, 2013),2 “the catch-
ment area must be defined and justified by the center based 
on the geographic area it serves. It must be population based, 
eg, using census tracts, zip codes, county or state lines, or 
geographically defined boundaries. It must include the local 
area surrounding the cancer center.”
Several methods have been proposed in the litera-
ture to define CAs for a health center of interest. A simple 
approach has been used to define the CA based on a par-
ticular measure of distance from the center, where the area 
inside a particular distance threshold composes the CA. 
Examples of this approach include Luo and Qi,3 who use a 
fixed distance (eg, 30 miles) or a travel time based on a road 
network to define a CA. Luo and Whippo4 use a threshold-
based population size to determine the distance for demar-
cating the CA. The main drawback of using this type of 
approach is that the threshold distance is deterministic and 
effectively arbitrary; it is not estimated from the observed 
data. Another approach using distance to define a CA is 
by Judge et al.5, who use Thiessen polygons to define a CA, 
where the Thiessen polygon for the center comprises all 
points in space that are closest to that center. This approach 
assumes that patients will travel to the facility that is clos-
est in Euclidean space.
Another approach to defining a CA uses patient flow data 
to determine a distance to define the CA. For example, Phibbs 
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and Robinson6 determined the distance radius that contained 
75% or 90% of hospital patients. Alexandrescu et al.7 define 
a CA by selecting areas that cumulatively account for 80% of 
hospital patients. Baker8 selects areas that contained a thresh-
old percent (eg, 0.5%) of the total facility activity. As with the 
distance-based approach, the main drawback of this approach 
is that the cumulative patient threshold (eg, 75% or 80% of 
patients) used to define the spatial boundary of the CA is not 
estimated from the data.
A different method proposed to define a CA is K-means 
clustering, which Gilmour1 uses to define a CA for a large hos-
pital in England based on three variables at the local authority 
district (LAD) level. Hospitals are run by Trusts in England, 
and for every Trust, a dataset of three variables was con-
structed, with one observation for each LAD that provided at 
least one patient admission to the hospital. The three variables 
were the proportion of hospital admissions coming from each 
LAD, the proportion of a LAD’s total admissions going to a 
given hospital, and the Euclidean distance between a hospital 
and an LAD. Separately for each Trust, the LAD data were 
divided into two clusters using K-means clustering with K = 2 
to define a CA for each Trust. In K-means clustering, dis-
tance refers to the distance between observations in a Euclid-
ean space with dimensions given by the variables of interest in 
the dataset, and variables need not be strictly based on geo-
graphic distance. One drawback of the use of this method as 
implemented in Gilmour1 is that the clustering analysis did 
not include any area-level demographic or patient covariates. 
An advantage of the K-means approach compared with the 
previously described approaches is that it estimates the CA 
extent based on several variables at the area level instead of 
deterministically specifying the spatial extent of the CA based 
on geographic distance.
Another approach for CA delineation that estimates the 
extent of the CA is based on a method used in disease cluster 
analysis. Su et al.9 use the local spatial scan implemented in 
the software SaTScan10 to define a CA for the Sidney Kimmel 
Comprehensive Cancer Center (SKCCC) at Johns Hopkins 
based on Johns Hopkins Hospital cancer registry’s patient 
counts in counties in seven adjacent states and the District of 
Columbia. The local spatial scan is generally used to detect a 
contiguous geographic area that differs statistically in some 
quantity from the surrounding area. For disease analysis, it 
is used to detect geographic areas of statistically significantly 
elevated disease risk. A disadvantage of the local spatial scan is 
that the analysis must be stratified to adjust for any important 
confounders. Su et al.9 use a Poisson model as the base for the 
local spatial scan, with SKCCC patient counts in the numera-
tor and total cancer deaths as the denominator (as a surrogate 
for the population with cancer) for the rate of SKCCC patient 
counts per cancer death for each county. Su et al created differ-
ent CAs for gender, cancer site (colon or lung, breast, pancreas, 
prostate), age group (,18 years, 18+), and race (white, African 
American). One drawback of the analysis by Su et al is that 
they did not use state registry data, and hence, only consider 
patients who visited SKCCC when estimating the CA extent. 
The total population with cancer was not known.
Onyile et al.11 also use the local spatial scan for creating 
a CA. Specifically, they use SaTScan to define a CA for a 
health information exchange in NYC, the New York Clinical 
Information Exchange (NYCLIX), with patient and census 
data from the three adjacent states of New York, New Jersey, 
and Connecticut. They use a Poisson model as the base model 
of the local spatial scan with the number of NYCLIX patients 
in each county and the number of people living in each county 
according to the 2010 census to calculate the relative risk of 
visiting the NYCLIX facility. They define the CA as a group 
of adjacent counties that each had a relative risk greater than 
1. One limitation of the analysis in Onyile et al.11 is that they 
did not use state registry data, but only patient data from the 
NYCLIX and at-risk population data from the U.S. Census.
The previously described approaches to creating a catch-
ment center for a health center each have their advantages, 
including ease of use, and disadvantages, including a lack of 
a statistical inference framework or the ability to account for 
covariates in the CA analysis. As an alternative, we propose to 
apply Bayesian hierarchical regression models to create CAs 
for a large health center. The Bayesian regression framework 
allows one to estimate a probability-based CA while making 
statistical inference and adjusting for patient demographic 
variables. Our objective in this work is to create CAs for a 
large cancer center, Massey Cancer Center (MCC) at the Vir-
ginia Commonwealth University Health System (VCUHS), 
which is seeking comprehensive cancer status from NCI. We 
used data from two different sources to construct a diagnosis 
CA for all cancers from state cancer registry data (Virginia 
Cancer Registry, VCR) and a diagnosis/treatment CA using 
patient billing data from MCC.
Methods
study data. VCR data. We obtained records from VCR 
for all diagnosed cancer patients during years 2009–2011 
living in the state of Virginia at the time of diagnosis. Ethi-
cal approval for the study was granted by the IRB of Vir-
ginia Commonwealth University. The VCR data included 
demographic variables gender, race, age, health insurance 
type, reporting hospital, and residential ZIP code at the 
time of diagnosis or treatment. Originally, the data con-
tained 160,307 records and 124,609 patients for the three 
years of study. We detected and deleted duplicated records 
for the same patient with the same cancer, tumor site, and 
diagnosed date, which was because of reporting of the same 
cancer for the same patient by different hospitals. After 
excluding duplicated records and records with missing val-
ues, we included 124,819 records and 118,452 patients in the 
CA analysis. Of those patients, 6,286 (5.3%) patients were 
diagnosed at MCC according to the reporting hospital coded 
in the VCR data.
Bayesian catchment area analysis
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MCC data. We obtained billing record data from MCC 
for all cancer patients diagnosed or treated at MCC during 
the period 2009–2012. The MCC data included demographic 
variables such as gender, race, date of birth, and health insur-
ance type and address at the time of diagnosis or treatment. 
The data contained 28,873 patients, of which 28,317 lived 
in the State of Virginia at the time of diagnosis or treatment 
at MCC. Of the 28,317 records, there were 24,576 records 
for treatment or diagnosis during the period 2009–2011. 
After excluding records with missing values for race, there 
were 24,537 patients diagnosed or treated at MCC during 
period 2009–2011 and 28,242 patients diagnosed or treated 
at MCC during period 2009–2012 who were included in the 
CA analysis.
statistical analysis. We used the cancer patient data 
from the two data sources to create two types of CAs. We 
first used the state cancer registry (VCR) data to create a CA 
map for diagnosis at MCC during 2009–2011. We then used 
the VCUHS billing data (MCC data) to create CA maps for 
diagnosis or treatment at MCC during 2009–2011 and dur-
ing 2009–2012. The first diagnosis/treatment CA analysis was 
limited in time (2009–2011) to correspond with the tempo-
ral range of VCR data, and the second diagnosis/treatment 
CA analysis (2009–2012) was intended to identify any change 
over time in the CA. For each patient dataset, we aggregated 
the data spatially to the county level to facilitate models with 
population subgroups based on patient demographics. CAs 
based on units smaller than a county were not of interest for 
the research presented here.
We used Bayesian hierarchical logistic regression to 
model the proportion of diagnosed cancer patients in each 
county in Virginia who were diagnosed at MCC during 
2009–2011. The demographic variables of patient race, gen-
der, and age were included in the logistic regression model 
to evaluate the relationship between the odds of diagnosis at 
MCC and patient characteristics. Random effects for counties 
were included to model residual variation in the odds of being 
diagnosed at MCC after adjusting for the demographic vari-
ables. We specified the logistic regression model as
log
p
p Male Age Black Other
ij
ij
ij ij ij ij1 0 1 2 3 3−





 = + + + + +β β β β β νi ,   
(1)
where pij is the probability of diagnosis at MCC for cancer 
patients located in the county i with covariate pattern
j i j, , , , , ,= =( )1 134 1 12… … , and vi is the county-specific 
random effect. The covariate patterns were defined by com-
binations of the demographic variables male (female as the 
reference level), age group of 65+ years (0–64 years as the ref-
erence level), and black and other non-white race (white as the 
reference level).
We considered two different priors for the random 
effects. The first was an exchangeable prior, which treats the 
random effects as independent, and the second was an intrin-
sic conditional autoregressive (CAR) prior,12 which assumes 
that random effects are correlated among neighboring coun-
ties, v CARi ~ τ( ), where τ is the precision. The intrinsic CAR 
distribution may be expressed as
   ν ν ν τi l i i iN m| ≠( ) ~ 1(( ),( ) /( )),  (2)
where mi is the number of adjacent counties for county i. The 
conditional mean of the distribution is ν ν
δ
i l
l in i
= ∑ , where δi  is 
the set of neighbors adjacent to county i. The deviance infor-
mation criterion (DIC) is used for comparing the goodness-
of-fit of Bayesian models. Models with smaller DIC are better 
than those with larger DIC.13 The exchangeable prior model 
had a meaningfully lower DIC value than the CAR prior, and 
we report results below only for the exchangeable prior model.
To model the rate of diagnosis or treatment at MCC, we 
used a Bayesian hierarchical Poisson regression model with 
the count of patients diagnosed or treated for cancer at MCC 
and a measure of the at-risk population count in each county. 
In order to see if the CA changed with additional data over 
time, we fitted separate Poisson regression models based on 
MCC data during 2009–2011 and MCC data during 2009–
2012. The population data to represent the at-risk popula-
tion were population counts by population subgroups from 
the 2010 U.S. Census. The demographic variable of black or 
other non-white race, with white as the reference level, was 
included in the model. Population counts were only available 
for individual covariates (not cross-tabulations of covariates), 
and we elected to adjust for one of the covariates most likely to 
be associated with diagnosis or treatment at MCC. Random 
effects for counties were included to model residual risk of 
being diagnosed or treated for cancer at MCC after adjusting 
for race. We specified the Poisson regression model hierarchi-
cally as
   
Y Poisson
e R
R Black Other
ij ij
ij ij ij
ij ij
~
0 1 2
µ
µ
β β β
( )
= ×
( ) = + +
,
,
log ij i+ν ,
 (3)
where Yij is the count of MCC-diagnosed/treated patients in 
county i with race j, µij is the unknown mean count, eij is the 
expected count of MCC-diagnosed/treated patients in county 
i with race j over all counties, Rij is the relative risk of popu-
lation diagnosed or treated at MCC in county i with race j
i j= =( )1 134 1 2 3, , , , ,… , and νi  is the county-specific random 
effect. The expected count eij was calculated as the count of 
MCC-diagnosed/treated patients with race j for all counties 
divided by the population with race j for all counties and then 
multiplied by the population in county i with race j. We again 
considered models with an exchangeable prior and with an 
intrinsic CAR prior. The exchangeable prior had the lower 
DIC, and we report results from this model below.
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For the priors for the logistic and Poisson models, the 
prior distribution for the intercept was an improper uniform 
prior dflat distribution, and the priors for the covariate regres-
sion coefficients were Normal 0 10 5, −( ), where 10‑5 represents 
the precision. The exchangeable prior for the random effects 
was normal with mean zero and precision τ1, which had a 
Gamma 0 5 0 0005. , .( ) prior. The CAR prior for the random 
effects had a precision τ 2  that had a Gamma 0 5 0 0005. , .( ) prior. 
The priors were selected to be conjugate priors.
We fitted the Bayesian regression models using R version 
3.0.0 software14 with package R2WinBUGS.15 In the Markov 
chain Monte Carlo (MCMC) procedure to estimate model 
parameters, we used two chains with a burn-in period of 
10,000 iterations and G = 10,000 subsequent samples from the 
joint posterior distribution to calculate posterior mean esti-
mates of the parameters for each model. Convergence of each 
model was assessed by the Brooks–Gelman–Rubin statistic,16 
where a value about 1 is considered as an indicator of conver-
gence of the MCMC.
To define CAs for MCC, we used exceedance probabili-
ties to assess unusual clustering of patients going to MCC. 
The exceedance probability is defined as qi i= >( )Pr θ 1 , which 
is an estimate of how frequently the odds ratio (OR) (logistic 
model) or the relative risk (Poisson model) exceeds the null 
value θi =( )1 . Under posterior sampling using MCMC, a con-
verged sample of θ θm m mp+ +{ }1 , ,…  can yield posterior expected 
estimates of these probabilities as
 
qi
i
g
g m
m m I
G
p
=
>( )( )
= +
+
∑
θ 1
1
, (4)
where G = mp and m is the number of burn-in samples. For the 
logistic model, the estimated OR for each county was calcu-
lated as meani iexp ν ν− ( )( ) where mean iν( ) is the mean of νi  
over all counties. For the Poisson model, the estimated rela-
tive risk for each county was directly obtained from the output 
of posterior sample simulation. The threshold of exceedance 
probabilities to define the CA was ˆ 0.90iq > . In other words, 
a county was marked as inside the CA if its exceedance prob-
ability was greater than 0.90. The threshold of 0.90 is a con-
ventional value in calculating exceedance probabilities in 
disease mapping.17 We also tried different threshold values for 
the exceedance probability, including values of 0.80, 0.85, and 
0.95. For the Poisson model, the CA was first created for each 
stratum of the demographic variable. A final CA for the Pois-
son model was constructed as a conflation of counties marked 
for inclusion in any of the stratum CAs. In other words, if a 
county was included in any stratum CA, it was included in the 
final CA.
For a comparison with our Bayesian regression methods, 
we also applied K- means clustering and the local spatial scan 
to both VCR and MCC datasets in the time period 2009–
2011. We did not adjust for demographic covariates with 
K-means clustering and the local spatial scan. The three 
variables for K-means clustering were the proportion of 
MCC patients coming from each county, the proportion of 
a county’s cancer patients going to MCC, and the Euclidean 
distance between MCC and a county centroid. For the local 
spatial scan, we used a Poisson model as the base model of the 
local spatial scan with the number of Massey patients in each 
county and the number of cancer people in each county (for 
VCR dataset) or the total population in each county according 
to the 2010 census (for MCC dataset) to calculate the relative 
risk of visiting MCC.
results
diagnosis cA. The regression parameter estimates and 
associated ORs for the Bayesian logistic model are shown in 
Table 1. All coefficients were significant at the level 0.05. Men 
had lower risk of being diagnosing at MCC than women, with 
an estimated OR of 0.88 (95% CI: 0.83, 0.93). Older patients 
(65+ years) had lower risk of being diagnosing at MCC than 
younger patients (,65 year), with an estimated OR of 0.42 
(95% CI: 0.40, 0.45). Blacks and those of other non-white 
race had higher risk of being diagnosing at MCC than whites, 
with estimated OR of 1.52 (95% CI: 1.42, 1.62) and 1.27 (95% 
CI: 1.04, 1.54), respectively. Hence, blacks were over 1.5 times 
more likely to be diagnosed at MCC than whites.
The CA map for diagnosis at MCC is shown in Figure 1 
using an exceedance probability threshold of 0.90. In all, 54 out 
of 134 counties in Virginia were included in the CA. The CA 
is centered in Richmond, as expected, and consists of a contig-
uous set of counties, along with the Eastern Shore of Virginia 
counties Northampton and Accomack. We also mapped the 
exceedance probabilities estimated from the Bayesian logistic 
regression model (Fig. 2) to show that the definition of the CA 
is not heavily dependent on the exceedance probability thresh-
old value. The number of counties in the estimated CA using 
the exceedance probability thresholds of 0.80, 0.85, and 0.95 
were 57, 54, and 53, respectively. For the following results, we 
used the threshold of 0.90.
Table 2 shows the number of all diagnosed cancer patients 
inside the CA and the number of MCC-diagnosed patients 
inside the diagnosis CA for all cancers. Among 11,303 diag-
nosed black patients inside the diagnosis CA, 2,173 (19.2%) 
patients were diagnosed at MCC. In contrast, MCC served 
12.1% of white patients diagnosed with cancer inside the CA. 
From this table, we see that MCC has served a relatively large 
proportion of those aged less than 65 years (19.1%) as well as 
patients who are black (19.2%), of other race (19.2%), Hispanic 
(30.9%), uninsured (41.5%), or on Medicaid (33.9%). Hence, 
MCC has been a center of cancer diagnosis for the tradition-
ally underserved populations of minorities and uninsured 
patients.
Table 3 shows characteristics of cancer patients diagnosed 
at MCC versus those not diagnosed at MCC, both inside and 
outside the MCC diagnosis CA for all cancers. Table 4 shows 
patient characteristics inside and outside the diagnosis CA for 
Bayesian catchment area analysis
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Table 1. Parameter estimates from the Bayesian logistic regression model for diagnosis Ca based on VCr data.
vARIABLE CoEffICIENT SE 95% CI P-vALUE  oR CI foR oR
Intercept ‑3.79 0.198 (‑4.18, ‑3.40) ,0.0001 – –
male ‑0.13 0.029 (‑0.19, ‑0.08) ,0.0001 0.88 (0.83, 0.93)
age2 (65) ‑0.86 0.030 (‑0.92, ‑0.80) ,0.0001 0.42 (0.40, 0.45)
Black 0.42 0.032 (0.35, 0.48) ,0.0001 1.52 (1.42, 1.62)
other 0.24 0.101 (0.04, 0.43) 0.0175 1.27 (1.04, 1.54)
Abbreviations: SE, standard error; CI, confidence interval; OR, odds ratio.
figure 1. Ca for diagnosis at mCC based on VCr data during  
2009–2011 for all cancers (n = 54 counties).
figure 2. map of exceedance probabilities for diagnosis at mCC based on VCr data during 2009–2011 for all cancers.
all cancers. Comparing these two tables, we see that 27.6% of 
patients inside the CA but not diagnosed at MCC were black, 
while 37.4% of the MCC patients inside the CA were black. 
Outside the CA, 13.6% of patients not diagnosed at MCC 
were black, while 25.5% of MCC patients were black. There-
fore, MCC has served a greater proportion of black patients 
both inside and outside the diagnosis CA. This is also true 
for younger patients, uninsured patients, and those on Medic-
aid. Inside the CA, there were higher proportions of patients 
diagnosed at MCC who were younger (65.9%), uninsured 
(11.2%), and on Medicaid (7.2%) than those younger (46.2%), 
uninsured (2.6%), and on Medicaid (2.3%) not diagnosed 
at MCC.
diagnosis/treatment cA. The CA for diagnosis/treatment 
at MCC is shown in Figure 3 for 2009–2011 and in Figure 4 
for 2009–2012. There were 44 out of 134 counties in Virginia 
included in the CA for diagnosis/treatment in 2009–2011, 
while 47 counties were included in the 2009–2012 CA. As 
with the diagnosis CA for 2009–2011, the diagnosis/treat-
ment CAs were centered on the city Richmond and were 
contiguous, with the exception of the inclusion of part of the 
Eastern Shore in 2009–2012. The CA increased in size by 
three counties when including data for 2012, suggesting that 
MCC expanded its service area over time. Specifically, the CA 
expanded slightly to the east and to the north. The 2009–2012 
CA added part of the Eastern Shore to the 2009–2011 CA, 
and it added a county in northern Virginia. The county mem-
bership for all three CAs is listed in Supplementary Table 1.
Though similar in shape to the diagnosis CA during 
2009–2011, the diagnosis/treatment CAs for 2009–2011 and 
2009–2012 are slightly smaller in spatial extent. For example, 
for 2009–2011, the diagnosis/treatment CA does not include 
any counties composing the Eastern Shore, and for 2009–
2012, it only includes one of the two counties composing the 
Eastern Shore. The diagnosis/treatment CAs also include two 
fewer counties on the western border of the CA. Even with 
these few differences, the diagnosis and diagnosis/treatment 
CAs are remarkably similar, despite being derived from two 
different datasets and statistical models.
Table 5 shows the number of MCC patients inside and 
outside the diagnosis/treatment CA for MCC in 2009–2012. 
Inside the CA, 30.4% of MCC-diagnosed/treated patients 
were black, while outside the CA, 25.3% of MCC-diagnosed/
treated patients were black. Therefore, MCC has served a 
greater proportion of black patients inside the diagnosis/
treatment CA than outside the CA during 2009–2012. There 
are also higher proportions of females (59.8%), older patients 
(39.4%), and those on Medicare (40.1%) diagnosed/treated 
at MCC inside the CA than females (50.1%), older patients 
(26.8%), and those on Medicare (29.5%) diagnosed/treated at 
MCC outside the CA.
Wang and Wheeler
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Table 2. total number of diagnosed cancer patients and mCC-diagnosed patients inside the diagnosis Ca for all cancers.
PATIENT gRoUPS ToTAL PATIENTS MCC PATIENTS PERCENT MCC
Gender male 20301 2635 13.0%
female 20677 3177 15.4%
age age (,65) 20084 3830 19.1%
age (65) 20894 1982 9.5%
race White 29042 3526 12.1%
Black 11303 2173 19.2%
other 633 113 17.9%
Hispanic Yes 2341 723 30.9%
no 38637 5089 13.2%
Insurance not insured 1591 660 41.5%
medicaid 1227 416 33.9%
medicare 18083 2025 11.2%
other 1400 62 4.4%
Unknown 2802 158 5.6%
Private 15875 2491 15.7%
 
Table 3. Patient characteristics for diagnosis Ca for mCC based on VCr data for all cancers. Percent values are based on numbers within each 
column.
PATIENT gRoUPS MCC PATIENTS  
INSIDE CA (%)
NoN-MCC PATIENTS  
INSIDE CA (%)
MCC PATIENTS  
oUTSIDE CA (%)
NoN-MCC PATIENTS 
oUTSIDE CA (%)
Gender male 2635 (45.3%) 17666 (50.2%) 230 (52.4%) 34937 (46.3%)
female 3177 (54.7%) 17500 (49.8%) 209 (47.6%) 40502 (53.7%)
age age (,65) 3830 (65.9%) 16254 (46.2%) 350 (79.7%) 37738 (50.0%)
age (65) 1982 (34.1%) 18912 (53.8%) 89 (20.3%) 37701 (50.0%)
race White 3526 (60.7%) 25516 (72.6%) 309 (70.4%) 61991 (82.2%)
Black 2173 (37.4%) 9130 (26.0%) 112 (25.5%) 10218 (13.5%)
other 113 (1.9%) 520 (1.5%) 18 (4.1%) 3230 (4.3%)
Hispanic Yes 723 (12.4%) 1618 (4.6%) 47 (10.7%) 9956 (13.2%)
no 5089 (87.6%) 33548 (95.4%) 392 (89.3%) 65483 (86.8%)
Insurance not insured 650 (11.2%) 931 (2.6%) 58 (13.2%) 2932 (3.9%)
medicaid 416 (7.2%) 811 (2.3%) 50 (11.4%) 2428 (3.2%)
medicare 2025 (34.8%) 16058 (45.7%) 105 (23.9%) 31718 (42.0%)
other 62 (1.1%) 1338 (3.8%) 10 (2.3%) 2236 (3.0%)
Unknown 158 (2.7%) 2644 (7.5%) 8 (1.8%) 5363 (7.1%)
Private 2491 (43.0%) 13384 (38.1%) 208 (47.4%) 30762 (40.8%)
Table 6 shows the total number of MCC-diagnosed/
treated cancer patients and the number of MCC-diagnosed/
treated cancer patients inside the CA for 2009–2012. From 
Table 6, we can see that 92.0% of MCC-diagnosed/treated 
black patients and 93.4% of MCC-diagnosed/treated older 
patients were captured inside the CA. Therefore, the diagno-
sis/treatment CA during 2009–2012 captures a relatively large 
proportion of MCC-diagnosed/treated patients.
The diagnosis CA maps based on K-means clustering and 
the local spatial scan are shown in Figures 5 and 6. The number 
of counties included in the CAs was 30 for K-means clustering 
and 42 for the local spatial scan. The diagnosis/treatment 
CA maps based on K-means clustering and the local spatial 
scan are shown in Figures 7 and 8. The number of counties 
included in the CAs was 33 for K-means clustering and 41 
for the local spatial scan. Compared with our Bayesian model 
diagnosis and diagnosis/treatment CAs, which contained 54 
and 44 counties, respectively, we see that K-means clustering 
and the local spatial scan yielded smaller CAs. The CAs over-
lap spatially to the extent that the Bayesian CAs effectively 
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figure 3. Ca for diagnosis/treatment for mCC based on mCC data in 
2009–2011 for all cancers (n = 44 counties).
figure 4. Ca for diagnosis/treatment for mCC based on mCC data in 
2009–2012 for all cancers (n = 47 counties).
Table 4. Patient characteristics for diagnosis Ca for mCC based on 
VCr data for all cancers. Percent values are based on the numbers 
within each column.
PATIENT gRoUPS ALL PATIENTS 
INSIDE CA (%)
ALL PATIENTS 
oUTSIDE CA (%)
Gender male 20301 (49.5%) 35167 (46.3%)
female 20677 (50.5%) 40711 (53.7%)
age age (,65) 20084(49.0%) 38088 (50.2%)
age (65) 20894 (50.1%) 37790 (49.8%)
race White 29042 (70.9%) 62300 (82.1%)
Black 11303 (27.6%) 10330 (13.6%)
other 633 (1.5%) 3248 (4.3%)
Hispanic Yes 2341 (5.7%) 10003 (13.2%)
no 38637 (94.3%) 65875 (86.8%)
Insurance not insured 1591 (3.9%) 2990 (3.9%)
medicaid 1277 (3.0%) 2478 (3.3%)
medicare 18083 (44.1%) 31823 (41.9%)
other 1400 (3.4%) 2246 (3.0%)
Unknown 2802 (6.8%) 5371 (7.1%)
Private 15875 (38.7%) 30970 (40.8%)
 
Table 5. Patient characteristics for 2009–2012 diagnosis/treatment 
Ca for mCC based on mCC data. Percent values are based on the 
numbers within each column.
PATIENT gRoUPS  MCC PATIENTS  
INSIDE CA (%)
MCC PATIENTS  
oUTSIDE CA (%)
Gender male 10278 (40.2%) 1333 (49.9%)
female 15290 (59.8%) 1341 (50.1%)
age age (,65) 15490 (60.6%) 1957 (73.2%)
age (65) 10078 (39.4%) 717 (26.8%)
race White 16784 (65.6%) 1849 (69.1%)
Black 7773 (30.4%) 676 (25.3%)
other 1011 (4.0%) 149 (15.8%)
Insurance not insured 2300 (9.0%) 348 (13.0%)
medicaid 3017 (11.8%) 356 (13.3%)
medicare 10252 (40.1%) 789 (29.5%)
other 436 (1.7%) 127 (4.7%)
Unknown 47 (0.2%) 6 (0.2%)
Private 9476 (37.1%) 1048 (39.2%)
 
contain not only the CAs estimated from K-means clustering 
and the local spatial scan but also adjacent counties.
discussion and conclusion
We used Bayesian hierarchical regression models to estimate 
diagnosis and diagnosis/treatment CAs for MCC using state 
cancer registry data, hospital billing data, and census data at 
the county level. Our results showed that the CAs for MCC 
were fairly large (n = 54 for diagnosis, n = 44 or 47 for diagnosis/
treatment), reflecting the significant presence of this large, 
urban cancer center in Virginia. The diagnosis/treatment CA 
increased slightly in size from 2009–2011 to 2009–2012. We 
also found that MCC has served a large proportion of black, 
Hispanic, and uninsured patients, and those on Medicaid. In 
addition to its large presence, MCC has played an important 
role as a care provider for traditionally underserved popula-
tions of cancer patients.
While the Bayesian hierarchical regression framework is 
well established, the application of these methods for defin-
ing CAs is novel. Existing methods for defining a CA are not 
probability based, may require a priori selection of a distance 
or patient flow threshold, or do not adjust easily for covariates. 
In contrast with previously proposed and applied approaches 
for CA analysis, the Bayesian regression models can estimate 
the CA stochastically from the data using exceedance prob-
abilities, while adjusting for several covariates. Estimating 
effects for patient demographics were beneficial for under-
standing differences in the likelihood of being seen at MCC 
according to patient characteristics. For example, we found 
that non-white patients were significantly more likely to be 
diagnosed at MCC than white patients. In addition, we could 
handle different types of available data with different forms 
of the regression model. Also, we could evaluate the benefit 
of including a prior on random effects that assume spatial 
correlation across counties by comparing a Bayesian measure 
of goodness-of-fit. In our case, including a spatially corre-
lated prior for county effects was unnecessary because of the 
strong spatial signal present in the patient data for being seen 
at MCC.
One limitation of our method is that the models are 
limited in the number of population group strata they 
can include. For example, if we increased the number of 
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figure 6. Ca map for diagnosis at mCC based on VCr data during 
2009–2011 for all cancers using the local spatial scan (n = 42 counties).
figure 7. Ca for diagnosis/treatment for mCC based on mCC data in 
2009–2011 for all cancers using K-means clustering (n = 33 counties).
figure 8. Ca for diagnosis/treatment for mCC based on mCC data in 
2009–2011 for all cancers using the local spatial scan (n = 41 counties).
Table 6. total number of mCC-diagnosed/treated cancer patients and total number of mCC-diagnosed/treated cancer patients inside 2009–
2012 diagnosis/treatment Ca based on mCC data.
PATIENT gRoUPS ToTAL MCC PATIENTS MCC PATIENTS INSIDE CA PERCENTAgE INSIDE CA
Gender male 11611 10278 88.5%
female 16631 15290 91.9%
age age (,65) 17447 15490 88.8%
age (65) 10795 10078 93.4%
race White 18633 16784 90.1%
Black 8449 7773 92.0%
other 1160 1011 87.2%
Insurance not insured 2648 2300 86.9%
medicaid 3373 3017 89.4%
medicare 11041 10252 92.9%
other 563 436 77.4%
Unknown 53 47 88.7%
Private 10524 9476 90.0%
 
figure 5. Ca map for diagnosis at mCC based on VCr data during 
2009–2011 for all cancers using K-means clustering (n = 30 counties).
categorical variables in the logistic model, we encountered 
a number of strata in some counties that had zero counts 
for cancer patients. The zero counts are problematic in the 
denominator when modeling the proportion. One solution is 
to add a small constant to the patient counts, but this arti-
ficially augments the data. Another solution is to adjust for 
a small number (relative to the number of observations) of 
categorical covariates. Yet another solution is to model data 
on an individual level, when available, which we will explore 
in future work. Another obstacle encountered when working 
with cancer registry data is multiple reporting of cancers by 
different hospitals or duplication of cancer records. The pres-
ence of such records requires additional data processing steps 
and the ability to identify unique patients through a unique 
identifier or a combination of variables, including diagnosis 
date, cancer type, tumor site, age, gender, race, etc. In addi-
tion, the cancer registry data do not include all types of can-
cer. For example, skin cancer is not reported to the VCR. 
However, diagnosis or treatment for skin cancer is captured 
in hospital billing records. While we could work with cancer 
registry data and hospital billing data separately, differences 
in composition of the cancer cases and covariates made it 
infeasible to use the data in combination.
Despite these limitations and obstacles, we were able 
to demonstrate the utility of applying Bayesian hierarchi-
cal regression models to define multiple CAs for a large 
Bayesian catchment area analysis
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cancer center. This framework for estimating CAs should be 
applicable to other large hospitals.
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